Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) EBIT Margin (2020 - 2024)

Historic EBIT Margin for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 58.17%.

  • ImageneBio's EBIT Margin rose 15876500.0% to 58.17% in Q3 2024 from the same period last year, while for Dec 2024 it was 1834.29%, marking a year-over-year decrease of 10110600.0%. This contributed to the annual value of 823.33% for FY2023, which is 3693400.0% down from last year.
  • As of Q3 2024, ImageneBio's EBIT Margin stood at 58.17%, which was up 15876500.0% from 3324.43% recorded in Q4 2023.
  • ImageneBio's 5-year EBIT Margin high stood at 13.81% for Q4 2021, and its period low was 40081.54% during Q4 2020.
  • Its 5-year average for EBIT Margin is 3205.03%, with a median of 292.02% in 2023.
  • As far as peak fluctuations go, ImageneBio's EBIT Margin skyrocketed by 400953500bps in 2021, and later tumbled by -51270700bps in 2022.
  • ImageneBio's EBIT Margin (Quarter) stood at 40081.54% in 2020, then soared by 100bps to 13.81% in 2021, then plummeted by -2108bps to 277.32% in 2022, then plummeted by -1099bps to 3324.43% in 2023, then soared by 98bps to 58.17% in 2024.
  • Its EBIT Margin stands at 58.17% for Q3 2024, versus 3324.43% for Q4 2023 and 1645.82% for Q3 2023.